Los Angeles, CA, United States of America

Anders M Eliasen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Scripps Research Institute. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anders M Eliasen. Retrieved from https://idiyas.com/inventor/anders-m-eliasen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Anders M Eliasen in Antiviral Research

Introduction

Anders M Eliasen is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of antiviral research, particularly in the development of pharmaceutical compositions aimed at combating human immunodeficiency virus (HIV). His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Eliasen holds a patent for "Antiviral prodrugs and pharmaceutical compositions thereof - Diesters of 4'-ethynyl-2-fluoro-2′-deoxyadenosine and aqueous parenteral suspensions thereof." This innovative patent provides extended in vivo viral suppression of HIV, showcasing his dedication to addressing critical health challenges.

Career Highlights

Anders M Eliasen is affiliated with the Scripps Research Institute, where he continues to engage in groundbreaking research. His work at this prestigious institution has allowed him to collaborate with leading scientists and contribute to significant advancements in antiviral therapies.

Conclusion

Anders M Eliasen's contributions to antiviral research and his innovative patent demonstrate his vital role in the fight against HIV. His work not only reflects his expertise but also his commitment to improving public health through scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…